Lung cancer cells have differential signaling responses to KRAS inhibitor treatment
Genetic alterations of the KRAS gene are some of the most common mutations in lung cancer patients, but unfortunately these patients have few effective treatment options. Drugs that target the G12C mutation in KRAS have shown ...
Mar 1, 2021
0
7